The increase in wound care treatment and management programmes is one of the key factors propelling the growth of the wound care biologics market. The rise in chronic wounds, particularly foot ulcers, among the diabetic population, as well as the rise in diabetes incidences caused by obesity, poor diet, and physical inactivity are driving Wound Care Biologics Market growth.
The huge burden of diseases, the focus on creating better treatment options, and the application of technology to combat inflammation, tissue accumulation, collagen deposition, and the formation of epithelial cell layers are all factors that have an impact on the market. The federal government's increased investment in encouraging the use of these solutions has a further impact on the market. The market for wound care biologics is also benefited by the rise in healthcare spending, improvements in the healthcare infrastructure, and high demand for expanded care delivery.
